Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Therapeutics crawled date : 2021 - 12 - 01 save search
Oncternal Therapeutics Reports Granting of Inducement Award Under Nasdaq Listing Rule 5635(c)(4)
Published: 2021-12-01 (Crawled : 23:00) - globenewswire.com
ONCT P | $8.79 -1.79% -1.82% 2.8K
|
Health Technology
|
| O: 0.36%
H: 3.2%
C: 2.14%
therapeutics granted grant
Gain Therapeutics to Participate at the Imagine AI + Healthcare Investor Summit
Published: 2021-12-01 (Crawled : 22:00) - biospace.com/
GANX | $3.2 0.63% 68K
|
Professional, Scientific, and T...
|
| O: 0.14%
H: 3.35%
C: -2.9%
therapeutics
Qualigen Therapeutics, Inc. Announces Closing of $8.82 Million Registered Direct Offering
Published: 2021-12-01 (Crawled : 21:00) - globenewswire.com
QLGN | $0.291 -2.15% -2.2% 27K
|
Health Technology
|
| O: -4.79%
H: 1.44%
C: -5.04%
offering therapeutics
Akari Therapeutics Presents New Data Revealing Potential Mechanism of Action Driving Serious Exacerbations Across Lung Disorders
Published: 2021-12-01 (Crawled : 20:00) - akaritx.com
AKTX | $1.225 9.26% 8.47% 8.8K
|
Health Technology
|
| O: 3.07%
H: 1.19%
C: -1.19%
order therapeutics potential
Werewolf Therapeutics to Present Preclinical Data on INDUKINE™ Molecules at the 63rd American Society of Hematology (ASH) Annual Meeting
Published: 2021-12-01 (Crawled : 17:00) - globenewswire.com
HOWL | $5.87 0.51% 0.51% 120K
|
Professional, Scientific, and T...
|
| O: 3.66%
H: 0.0%
C: -8.79%
ema therapeutics preclinical pre-clinical
Relmada Therapeutics to Present Data at the 60th Annual Meeting of the American College of Neuropsychopharmacology
Published: 2021-12-01 (Crawled : 14:30) - biospace.com/
RLMD | $4.28 -8.55% -9.35% 86K
|
Health Technology
|
| O: 2.35%
H: 0.0%
C: -6.4%
therapeutics
Regulus Therapeutics Announces Presentation at the First Annual Rare & Genetic Kidney Disease Drug Development Summit
Published: 2021-12-01 (Crawled : 14:30) - biospace.com/
RGLS | $2.22 -5.13% -5.41% 200K
|
Health Technology
|
| O: -1.94%
H: 1.32%
C: -4.71%
genetic drug therapeutics presentation disease kidney rare
Allogene Therapeutics Announces Conference Call to Review ALPHA, ALPHA2 and UNIVERSAL Phase 1 Data Presented at the 2021 American Society of Hematology Annual Meeting
Published: 2021-12-01 (Crawled : 14:00) - biospace.com/
ALLO | $3.455 -1.57% -1.59% 1.2M
|
Health Technology
|
| O: 3.34%
H: 5.42%
C: -0.27%
ema conference therapeutics phase 1
Virios Therapeutics Achieves Over 50% Enrollment Milestone in its Phase 2b Clinical Trial for Fibromyalgia
Published: 2021-12-01 (Crawled : 13:30) - biospace.com/
VIRI | $0.433 -3.97% -4.13% 59K
|
Health Technology
|
| O: 14.52%
H: 0.0%
C: -8.15%
phase 2 phase 2b fibromyalgia trial therapeutics enroll milestone
SAB Biotherapeutics Announces SAB-176 Met its Primary Endpoint in Phase 2a Challenge Study in Adults Infected with Influenza Virus
Published: 2021-12-01 (Crawled : 13:30) - biospace.com/
SABS | $4.61 0.22% 0.22% 2.9K
|
|
| O: 1.77%
H: 10.82%
C: 3.02%
phase 2 therapeutics influenza iot sab-176 diversitab infections phase 2b
Parthenon Therapeutics Appoints Tamas Oravecz, Ph.D., as Chief Scientific Officer
Published: 2021-12-01 (Crawled : 13:00) - biospace.com/
JNJ | News | $145.74 0.67% 0.0% 9.3M
|
Health Technology
|
| O: -1.03%
H: 2.04%
C: 0.76%
BMY | $48.295 0.95% 0.0% 11M
|
Health Technology
|
| O: -0.66%
H: 0.0%
C: 0.0%
therapeutics vtama
Arch Therapeutics Adds Key Opinion Leader Interview on Diabetic Foot Ulcers to the Experts in Wound Care Program
Published: 2021-12-01 (Crawled : 13:00) - globenewswire.com
ARTH | $1.16 -17.78% 1.9K
|
Manufacturing
|
| O: 0.0%
H: 1.32%
C: 1.32%
therapeutics wound care diabetic diabetes
Horizon Therapeutics plc Provides Academic Scholarships to Help Economically Disadvantaged Students in Ireland Further Their STEM Education
Published: 2021-12-01 (Crawled : 12:30) - biospace.com/
HZNP | $116.3 0.03% 29M
|
Health Technology
|
| O: 3.24%
H: 3.08%
C: 0.87%
therapeutics education
BioXcel Therapeutics Announces Extension of FDA Review Period of its NDA for BXCL501 for the Acute Treatment of Agitation Associated with Schizophrenia and Bipolar Disorders
Published: 2021-12-01 (Crawled : 12:30) - globenewswire.com
BTAI | $2.56 -1.16% -1.17% 240K
|
Health Technology
|
| O: -13.2%
H: 11.23%
C: 8.21%
treatment fda schizophrenia order therapeutics
G1 Therapeutics Initiates Phase 2 Trial to Support the Antitumor Mechanism of Action (MOA) of Trilaciclib in the Tumor Microenvironment
Published: 2021-12-01 (Crawled : 12:30) - globenewswire.com
GTHX | News | $4.16 -2.8% -2.88% 690K
|
Health Technology
|
| O: 6.41%
H: 0.0%
C: 0.0%
phase 2 trilaciclib trial therapeutics
Silence Therapeutics Welcomes Deep Track Capital as New Shareholder
Published: 2021-12-01 (Crawled : 12:30) - globenewswire.com
SLNCF | $8.0 -65.0% 1.3K
|
Health Technology
|
| O: 4.52%
H: 0.0%
C: 0.0%
SLN | $21.93 1.72% 120K
|
Health Technology
|
| O: 4.47%
H: 5.3%
C: 1.83%
therapeutics
Sage Therapeutics and Biogen Announce Positive, One-Year Zuranolone 50 mg Data in the Ongoing Open-Label SHORELINE Study in Patients with MDD
Published: 2021-12-01 (Crawled : 12:30) - biospace.com/
SAGE | News | $13.03 3.66% 3.53% 1.8M
|
Health Technology
|
| O: 1.76%
H: 0.51%
C: -5.42%
BIIB | $190.55 -0.84% -0.84% 1.5M
|
Health Technology
|
| O: 0.21%
H: 1.1%
C: -3.16%
ongoing therapeutics positive
Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Published: 2021-11-30 (Crawled : 00:00) - globenewswire.com
SRPT | $116.59 -1.1% -1.12% 450K
|
Health Technology
|
| O: 1.14%
H: 5.73%
C: 1.9%
therapeutics granted grant
Gainers vs Losers
| 64% | 36% |
Top 10 Gainers
AGBA | $1.02 155.0% 60.78% 120M
|
Finance
INVO | $1.555 104.6% 51.13% 5M
|
Health Technology
ISPC | $0.437 105.16% 49.53% 37M
|
Professional, Scientific, and T...
WLGS | $0.92 84.0% 45.65% 900K
|
OST | $0.499 21.38% 45.26% 1.9M
|
ZCMD | $2.44 78.1% 43.85% 330K
|
Commercial Services
XPON | $3.1 60.62% 37.74% 16M
|
TIRX | $0.7 44.39% 30.74% 58M
|
BNTC | $6.92 44.17% 30.64% 3.5M
|
Health Technology
GGE | $0.035 19.86% 29.3% 64M
|
Your saved searches
Save your searches and get alerts when important news are released.